Safety check: does a migraine drug affect pregnancy?
NCT ID NCT05198245
Summary
This study looks back at medical records to see if taking the migraine medication rimegepant during pregnancy is linked to any risks for the mother or baby. It compares pregnancy outcomes in three groups: women with migraines who took rimegepant, women with migraines who took other medications, and women without migraines. The goal is to gather safety information for pregnant women who need migraine treatment.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MIGRAINE are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Pfizer
New York, New York, 10001, United States
Conditions
Explore the condition pages connected to this study.